The cholinergic hypothesis of memory dysfunction in Alzheimer's disease--revisited
Pomara, N.; Stanley, M.
Psychopharmacology Bulletin 22(1): 110-118
1986
ISSN/ISBN: 0048-5764 PMID: 3726056 Document Number: 284298
Document emailed within 1 workday
Related Documents
Robert, P.H.; Gokalsing, E.; Bertogliati, C. 1999: Cholinergic hypothesis and Alzheimer's disease: the place of donepezil (Aricept) L'Encephale 25(Special Issue 5): 23-27; Discussion: 28-29Mukhin, V.N. 2013: Pathogenesis of the basal forebrain cholinergic dysfunction in Alzheimer's disease Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 99(7): 793-804
Wang, Y. 2014: Strongly recommend to put the "memory assessment" into the project of the adult annual wellness visit: experts' consensus of the Alzheimer's Disease Chinese (ADC) about "memory screening" Zhonghua Nei Ke Za Zhi 53(12): 929
Bradley, R.J.; Edge, M.T.; Freeman, A.M. 1991: The effects of cholinergic preparations in Alzheimer's disease Farmakologiia i Toksikologiia 54(3): 4-10
Kurz, A.; Rüster, P.; Romero, B.; Zimmer, R. 1986: Cholinergic treatment strategies in Alzheimer's disease Der Nervenarzt 57(10): 558-569
Lawrence, A.D.; Sahakian, B.J. 1995: Alzheimer disease, attention, and the cholinergic system Alzheimer Disease and Associated Disorders 9(Suppl 2): 43-49
Tucek, S. 1987: Cholinergic mechanisms in the brain and their impairment in Alzheimer's disease Ceskoslovenska Psychiatrie 83(1): 36-45
Clader, J.W. 1999: Recent advances in cholinergic drugs for Alzheimer's disease Current Opinion in Drug Discovery and Development 2(4): 311-320
Braginskaia, F.I.; Zorina, O.M.; Pal'mina, N.P.; Gaintseva, V.D.; Burlakova, E.B.; Selezneva, N.D.; Kolykhalov, I.V.; Gavrilova, S.I. 2000: Certain biochemical blood markers in the process of cholinergic therapy in Alzheimer's disease Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(6): 29-32
Becker, J.T.; Overman, A.A. 2002: The semantic memory deficit in Alzheimer's disease Revista de Neurologia 35(8): 777-783
Tamaoka, A. 2013: The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis" Rinsho Byori. Japanese Journal of Clinical Pathology 61(11): 1060-1069
Gillen, T.E.; Gregg, K.M.; Yuan, H.; Kurth, M.C.; Krishnan, K.R. 2001: Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease Psychopharmacology Bulletin 35(2): 83-96
Kowalska, A. 2004: The beta-amyloid cascade hypothesis: a sequence of events leading to neurodegeneration in Alzheimer's disease Neurologia i Neurochirurgia Polska 38(5): 405-411
Williams, L.R.; Jodelis, K.S.; Donald, M.R. 1989: Regional stimulation of cholinergic function by nerve growth factor in an animal model of Alzheimer's disease Progress in Clinical and Biological Research 317: 1179-1192
Harbaugh, R.E. 1987: Intracerebroventricular cholinergic drug administration in Alzheimer's disease: preliminary results of a double-blind study Journal of Neural Transmission. Supplementum 24: 271-277
Mormont, E.; Laurier-Grymonprez, L.; Baisset-Mouly, C.; Pasquier, F. 2003: The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease Revue Neurologique (Paris) 159(8-9): 762-766
Zhu, S.-x.; Sun, G.-j. 2009: Effects of electroacupuncture on learning and memory ability and glial cells of the hippocampus in the rat of Alzheimer disease Zhongguo Zhen Jiu 29(2): 133-136
Fisher, A.; Brandeis, R.; Karton, I.; Pittel, Z.; Gurwitz, D.; Haring, R.; Sapir, M.; Levy, A.; Heldman, E. 1991: (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease Journal of Pharmacology and Experimental Therapeutics 257(1): 392-403
Meng, Q.H.; Lou, F.L.; Hou, W.X.; Liu, M.; Guo, H.; Zhang, X.M. 2013: Acetylpuerarin reduces inflammation and improves memory function in a rat model of Alzheimer's disease induced by Abeta1-42 Die Pharmazie 68(11): 904-908
2011: Dysfunction of cognitive and memory spheres during vibration disease in miners of Kouzbass Meditsina truda i promyshlennaia ekologiia 2011(12): 43-48